Turn this list into pipeline.
Pharmaceutical Companies in Leeds: 200+ Active Firms (2026)
Pharmaceutical companies in Leeds research, develop, manufacture or distribute regulated medicines across the city’s life-sciences economy.
Buying activity tends to sit with quality, regulatory, procurement and clinical operations teams rather than a software-style buyer. Leeds suppliers in this field usually sell regulated inputs or capacity into healthcare providers, clinical research organisations, pharmacies, wholesalers and export channels. Engagements are rarely impulse purchases: customers expect licence coverage, batch documentation, audit trails, temperature-controlled logistics where relevant, and evidence that medicines can move through compliant manufacturing or distribution processes. The better-fit commercial relationships are therefore contract, tender or framework based, with due diligence led as much by responsible persons and quality assurance staff as by commercial teams.
Read more
Leeds has 269 actively trading pharmaceutical companies, making this a compact city cohort rather than a broad national cluster. Reported headcount totals 489 people, so the employment footprint looks fairly small relative to the regulatory burden attached to medicines work. Turnover disclosure points in the same direction: only 5 sit above £5M, while 74 have been incorporated since 2022. That mix suggests a long tail of early-commercial distributors, development-services firms and specialist operators alongside a small group with more mature revenue reporting.
Human medicines in the UK sit under MHRA oversight, with activity-specific obligations rather than blanket permission. GOV.UK guidance says organisations making, assembling or importing human medicines need a manufacturer’s licence, good manufacturing practice compliance and regular site inspections; wholesale supply to anyone other than the patient brings wholesale distribution licensing and good distribution practice. Marketing authorisation remains a separate gate, and public reimbursement adds cost-effectiveness assessment before medicines can reach routine use. The ABPI is the main trade body for research-based pharmaceutical companies, which matters for a Leeds cohort spanning distribution, development services and smaller manufacturing activity.
The Leeds cohort appears likely to remain shaped by compliance capacity as much as by scientific or commercial demand. Smaller operators can serve defensible niches in development support, import, wholesale and specialist supply, but licensing, responsible-person coverage and inspection readiness tend to limit casual expansion. Scale-up scarcity may therefore persist, with mature operators more able to absorb quality-system costs or acquire regulated routes to market. Pressure on public purchasing and evidence standards also favours firms that can document reliability, traceability and clinical value without relying on speculative volume growth.
269
Active firms
2026
5
Above £5M
Revenue threshold
74
Since 2022
Recent incorporations
Key facts
About 1% of the trading cohort reports turnover above £5M (5 of 269 firms) — the rest sits below that revenue band.
27% of the cohort was incorporated since 2022 (74 firms), so a sizeable share is in its first few filing cycles.
MHRA sets standards, evaluates new treatments, approves clinical trials, licenses medicines and oversees pharmacovigilance.
Organisations that make, assemble or import human medicines need an MHRA manufacturer’s licence, good manufacturing practice compliance and regular site inspections.
Wholesale supply to anyone other than the patient requires a wholesale distribution licence and good distribution practice compliance.
Pharmaceuticals accounted for £9.0 billion of UK business R&D in 2022, equal to 18% of all UK business R&D.
UK pharmaceutical exports were valued at £25.6 billion in 2023, with the UK ranked tenth among comparator countries for this metric.
Top Leeds pharmaceutical companies
IPHARMA 2 LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsWholesale pharmaceutical distributor supplying generic and over‑the‑counter medicines, prescription drugs, hospital products and specialist liquid medications. Provides contract distribution and…
Serves healthcare organisations including hospitals, doctors’ surgeries, pharmacies and care homes, targeting buyers of generic, OTC, prescription, hospital and specialist medicine lines.
Financial Health
HealthyHealthy · Growing · 0% CAGR over 4y
Location
NANOPHARM LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsProvides contract research and development services for nasal and inhaled drug products. Offers formulation development, particle engineering, spray characterization, analytical testing, in‑vitro and…
Serves pharmaceutical and biotech companies developing nasal and inhaled drug-device products, including innovators, generics manufacturers and teams managing lifecycle, reformulation or…
Financial Health
WeakWeak · Hiring · 13% CAGR over 2y
Location
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsOperates an automated hub-and-spoke prescription dispensing facility for independent pharmacies. Provides offsite dispensing, medication supply, and technology integration with pharmacy systems,…
Sells to independent community pharmacies and pharmacy groups in the UK, particularly owners and pharmacists seeking outsourced hub-and-spoke dispensing capacity to support NHS and private clinical…
Financial Health
StableStable · 0% CAGR over 1y
Location
Trajectory
4y · 2020–NowFinancial sub-scores
Computed from 4 filingsProvides automated prescription dispensing services for independent pharmacies using a hub‑and‑spoke model. Operates a centralised facility that dispenses prescriptions offsite, integrates with…
Serves independent community pharmacies and pharmacy groups in the UK, particularly owners and pharmacists seeking capacity to expand NHS and private clinical services.
Financial Health
StrongStrong · Hiring · 46% CAGR over 3y
Location
D&A Pharma Services Ltd
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops and commercialises pharmaceutical products targeting addiction and rare diseases, focusing on sodium oxybate formulations for alcohol use disorder. Conducts drug research and development,…
Serves European healthcare markets focused on addiction and neuropsychiatric care, including clinicians, treatment centres, hospitals, pharmacies and patients with alcohol use disorder or related…
Financial Health
StrongStrong · Hiring · 15% CAGR over 2y
Location
LUNAC THERAPEUTICS LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDevelops anticoagulant drug candidates for the prevention and treatment of thrombotic blood clots. Conducts research and discovery of small‑molecule therapies targeting activated Factor XII (FXIIa)…
Serves the healthcare sector, targeting clinicians and organisations managing patients who need anticoagulant therapy for prevention or treatment of life-threatening thrombotic events.
Financial Health
DistressedDistressed · -29% CAGR over 2y
Location
Global Pharm Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures pharmaceutical products including finished formulations, sterile eye and ear drops, parenterals, and active pharmaceutical ingredients. Provides contract manufacturing, nutraceutical and…
Serves B2B pharmaceutical companies, healthcare distributors and market-entry partners worldwide seeking finished formulations, APIs, nutraceuticals, OTC products and contract manufacturing support.
Financial Health
HealthyHealthy · Hiring · 6% CAGR over 4y
Location
Fountain RX Limited
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsProvides specialty pharmacy services including dispensing and compounding prescription medicines, infusion therapy support, and medication management for patients with chronic or rare conditions,…
Serves patients with chronic or rare complex health conditions, plus healthcare providers, pharmaceutical companies and payors involved in specialty medication access, adherence and outcomes.
Financial Health
DistressedDistressed · -11% CAGR over 3y
Location
Amo Pharma Limited
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsDevelops and advances pharmaceutical treatments for serious and rare diseases, including genetic, neuromuscular and central nervous system disorders. Conducts clinical research and drug development…
Serves patients and healthcare stakeholders focused on serious debilitating diseases, especially rare genetic disorders with neuromuscular or CNS symptoms such as congenital myotonic dystrophy,…
Financial Health
DistressedDistressed · -20% CAGR over 1y
Location
Pharmacy2U
Operates an NHS‑approved online pharmacy providing repeat prescription management and home delivery of prescription medicines. Also offers online doctor consultations and sells over‑the‑counter…
Serves UK consumers and NHS patients, especially people managing repeat prescriptions, plus shoppers seeking over-the-counter medicines, health, wellbeing and personal care products, and private…
Location
AUTONO-MED LIMITED
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
HUNTER UROLOGY LTD
Trajectory
2y · 2020–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
StrongStrong · Growing · 0% CAGR over 1y
Location
Provides contract research organisation services to pharmaceutical, biotechnology and medical device companies, including clinical trial management, clinical pharmacology studies, data management,…
Serves biopharma, pharmaceutical, biotechnology and MedTech companies worldwide, including teams developing drugs, devices and diagnostics across Phase I–IV clinical programs and post-approval…
Location
SPRINGFALL UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsOperates an NHS‑approved online pharmacy supplying prescription and over‑the‑counter medicines. Provides prescription dispensing, repeat prescription management and home delivery, along with pharmacy…
Serves consumers and NHS patients in England/UK seeking online pharmacy access, prescription support, over-the-counter health products, community pharmacy advice, vaccinations and travel health…
Financial Health
HealthyHealthy · Hiring · 57% CAGR over 4y
Location
The PharmPet Co Limited
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsOperates an online pharmacy providing NHS repeat prescription ordering and home delivery, private online doctor consultations, and e‑commerce sales of over‑the‑counter medicines, health products,…
Serves consumers and NHS patients seeking repeat prescription delivery, private online doctor consultations, and retail health, pharmacy, wellbeing and beauty products.
Financial Health
HealthyHealthy · 0% CAGR over 1y
Location
Pharmacy2u
Operates an online pharmacy providing NHS repeat prescription ordering and home delivery, private online doctor consultations, and e‑commerce sales of over‑the‑counter medicines, health products,…
Serves UK consumers and NHS patients seeking repeat prescriptions, private online doctor access, over-the-counter medicines, health products, wellbeing items and personal care products.
Location
LIVING CARE PHARMACY (WAKEFIELD) LIMITED
Trajectory
3y · 2022–NowFinancial sub-scores
Computed from 3 filingsDispenses NHS prescriptions and provides online repeat prescription ordering with home delivery or in‑store collection. Offers pharmacy services and medicines management support for residential and…
Serves NHS prescription patients seeking home delivery or local collection, primarily in Yorkshire, plus residential and nursing care homes needing pharmacy support for residents and regulatory…
Financial Health
DistressedDistressed
Location
Kpharm Enterprises Ltd
Trajectory
1y · 2025–NowOperates an online shop supplying aesthetic medicine products, including botulinum toxin injectables, dermal fillers, skin boosters, lipolytic solutions, PDO threads, and related medical devices and…
Sells primarily to aesthetic medicine businesses and practitioners, including cosmetic clinics, medspas and injectable treatment providers sourcing Korean aesthetics products and devices.
Financial Health
Insufficient historyInsufficient history
Location
Fpd Group Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · -16% CAGR over 4y
Location
MED FRONTIER SUPPLIERS & CONSULTANCY UK LIMITED
Trajectory
2y · 2024–NowFinancial sub-scores
Computed from 2 filingsFinancial Health
DistressedDistressed
Location
Bless You Ltd
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed
Location
DEBRINCH KD LTD
Trajectory
4y · 2022–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
DistressedDistressed
Location
Skin Cell Labs Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
PHARM-X LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsProvides contract development and manufacturing services (CDMO) for pharmaceutical companies, specialising in aseptic sterile fill‑finish, drug product filling, and packaging. Supports pharmaceutical…
Sells to pharmaceutical companies and drug developers needing aseptic CDMO support, including sterile fill-finish and packaging services, from concept through commercialisation. Targets innovators…
Financial Health
StrongStrong · Growing, Hiring · 26% CAGR over 4y
Location
Accord Healthcare
Develops, manufactures and distributes generic, biosimilar and specialty medicines for hospital and retail pharmacies. Portfolio spans treatments in oncology, cardiology, neurology, psychiatry,…
Serves hospital and retail pharmacies, healthcare providers and patient advocacy groups worldwide, with medicines used across oncology, cardiology, neurology, psychiatry, diabetes, pain management…
Location
Accord Healthcare
Develops, manufactures and distributes generic, biosimilar and other pharmaceutical medicines for hospital and retail pharmacy markets. Portfolio includes treatments across areas such as oncology,…
Serves hospital and retail pharmacies, healthcare systems and the wider healthcare community needing generic, biosimilar and added-value medicines across therapeutic areas including oncology,…
Location
Certified Health Limited
Trajectory
4y · 2021–NowFinancial sub-scores
Computed from 4 filingsFinancial Health
DistressedDistressed
Location
MAP CRESCENT UK LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsManufactures and distributes generic pharmaceutical medicines. Operates production, warehousing and distribution for solid and liquid drug products, supplying hospitals, pharmacies, wholesalers and…
Serves the UK healthcare supply chain, including the NHS, Department of Health, pharmaceutical wholesalers, distributors, pharmacies, hospitals, clinics and other healthcare providers, with patients…
Financial Health
DistressedDistressed · 0% CAGR over 4y
Location
S M C SOLUTIONS LTD
Trajectory
2y · 2023–NowFinancial sub-scores
Computed from 2 filingsProvides contract manufacturing for medical device and pharmaceutical companies, including product design and development, tooling and mold design, silicone injection molding, sterile filling,…
Serves B2B customers in medtech, diagnostics and pharmaceutical sectors, including teams developing medical devices, autoinjectors and sterile drug-device products from prototype through commercial…
Financial Health
StableStable · Hiring · 12% CAGR over 1y
Location
OPTIGEN PHARMA LTD
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Saxon Pharmaceuticals Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StableStable · 0% CAGR over 4y
Location
Develops and supplies pharmaceutical products including generic, biosimilar, and specialty medicines. Produces biopharmaceutical treatments and provides medicines for areas such as CNS disorders,…
Serves the NHS and UK healthcare providers, with medicines used by patients and caregivers managing conditions including CNS, migraine, respiratory, oncology, pain and consumer health.
Location
SH Healthcare Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsSupplies pharmaceutical products and bulk pharma molecules, including peptides and formulations such as antispasmodics, calcium and health supplements, haematinics, analgesics, gastrointestinal,…
Serves pharmaceutical buyers, healthcare distributors and trade customers seeking bulk pharma molecules and therapeutic products across multiple categories, with an emphasis on global markets.
Financial Health
StableStable · 2% CAGR over 4y
Location
ZERODERMA LIMITED
Trajectory
3y · 2023–NowFinancial sub-scores
Computed from 3 filingsDevelops and supplies emollient skincare products for dry skin conditions including eczema, psoriasis and ichthyosis. Product range includes creams, ointments and gels formulated without fragrance or…
Serves UK consumers and patients managing eczema, ichthyosis, psoriasis and other dry skin conditions, plus healthcare professionals such as doctors, pharmacists and nurses who prescribe or recommend…
Financial Health
StableStable
Location
Ruqayyah Z Ltd
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
HAQ PHARM LTD
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
Alpharma Limited
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · 0% CAGR over 4y
Location
Develops, manufactures and supplies generic, biosimilar and specialty pharmaceutical medicines. Produces treatments across areas such as central nervous system, migraine, respiratory, oncology and…
Serves the NHS and wider UK healthcare system, including healthcare professionals and organisations involved in patient care, while also addressing patients and caregivers across CNS, migraine,…
Location
Develops, manufactures and supplies generic, biosimilar and specialty medicines and biopharmaceuticals. Provides treatments across areas including central nervous system disorders, migraine,…
Serves the NHS and UK healthcare organisations, with a patient base across CNS, migraine, respiratory, oncology, pain and consumer health; also addresses UK patients and caregivers seeking medicine…
Location
Develops and supplies pharmaceutical products including generic medicines, specialty drugs and biosimilars, supporting the manufacture and distribution of treatments across therapeutic areas such as…
Serves the NHS and UK healthcare providers, as well as patients and caregivers seeking information and support across CNS, migraine, respiratory, oncology, pain and consumer health areas.
Location
Develops, manufactures and supplies generic, biosimilar and specialty medicines, including treatments for central nervous system, respiratory, oncology and pain conditions. Also provides…
Serves the NHS and UK healthcare providers, with resources aimed at patients and caregivers managing conditions across areas such as central nervous system disorders, migraine, respiratory disease,…
Location
Shj Pharma Ltd
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Sterling Pharma Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
WeakWeak · 0% CAGR over 4y
Location
KKAURPHARMA LIMITED
Trajectory
5y · 2020–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
StrongStrong
Location
IL LOCUM LTD
Trajectory
5y · 2022–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · 0% CAGR over 4y
Location
Dr Reddy's Laboratories (EU) Limited
Trajectory
4y · 2023–NowFinancial sub-scores
Computed from 4 filingsDevelops, manufactures and supplies generic medicines, biosimilars and active pharmaceutical ingredients. Provides pharmaceutical development and manufacturing services and markets specialty,…
Serves healthcare providers, patients, pharmacies and consumers, with B2B relationships with pharmaceutical companies needing APIs, development, manufacturing and research support across global…
Financial Health
HealthyHealthy · Hiring · 4% CAGR over 3y
Location
FW HEALTH LTD
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsDistributes and markets consumer healthcare and medical device products, including gastrointestinal and skincare gels. Provides UK market entry support for healthcare brands, covering regulatory…
Sells primarily to healthcare brands and distributor partners seeking UK market entry or expansion, plus pharmaceutical distributors and healthcare partners in international markets. Serves trade…
Financial Health
WeakWeak · 0% CAGR over 4y
Location
MistryPharm Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
HealthyHealthy · 0% CAGR over 4y
Location
Yourmedicines2u Limited
Trajectory
5y · 2021–NowFinancial sub-scores
Computed from 5 filingsFinancial Health
DistressedDistressed · -18% CAGR over 4y
Location
HEALTH CLINIC PRO LTD
Trajectory
1y · 2025–NowFinancial Health
Insufficient historyInsufficient history
Location
Unlock all 269 leads
Showing 50 of 269 — +219 more with verified decision-maker contacts, live data, and CRM sync.
How Leeds pharmaceutical companies work and how to sell to them
What they do
Leeds pharmaceutical businesses tend to earn revenue through a mix of product supply, regulated distribution margin, contract manufacturing or assembly fees, import services, and development-support work for medicines moving towards authorisation. Commercial terms are usually tied to batches, packs, projects, storage volume, release milestones or retained access to specialist capacity rather than pure subscriptions. A software-like recurring model can appear around data, safety or compliance services, but the core economics are closer to regulated supply and outsourced operations. Buyers pay for documented control as much as physical stock: validated processes, certificates, stability evidence, deviation handling and audit readiness all affect price and renewal.
Who they sell to
Their customers are typically hospital and pharmacy channels, healthcare providers, clinical research organisations, wholesalers, medicine developers and overseas distributors that need UK-regulated supply or support. Decision makers often include quality directors, regulatory affairs leads, responsible persons, procurement heads, clinical operations managers and finance teams, with commercial sponsors brought in once compliance risk is understood. Smaller orders may be handled through direct account relationships, while larger supply or service agreements tend to involve tenders, approved-supplier onboarding, technical questionnaires and site audits. Sales cycles are usually measured in months, because the buyer must check licences, quality systems, batch documentation, continuity planning and liability before committing volume.
What they buy
Most Leeds pharmaceutical firms tend to spend on tools and services that reduce quality-system friction or protect controlled movement of medicines. Common buying categories include document management, electronic quality management, batch and inventory systems, temperature monitoring, warehouse management, pharmacovigilance workflows, validation support, cyber security, finance systems and contract lifecycle management. They also buy specialist legal advice, regulatory consultancy, insurance, outsourced accounting, recruitment for quality and operations roles, packaging, laboratory services, courier and cold-chain capacity, premises support and waste handling. Generic productivity software is a harder sell unless it maps to an audit trail, inspection finding, stock-control issue or release bottleneck.
Why and how to sell to them
Commercial intent often appears when a firm adds a new regulated activity, changes responsible-person cover, prepares for an MHRA inspection, wins a distribution route, takes on a hospital or pharmacy customer, or moves from ad hoc project work into repeat supply. Other triggers include leadership changes, new warehouse or laboratory space, overseas demand, quality findings, recall exposure and headcount growth in regulatory or operations roles. Outbound messages tend to land better when they speak to evidence, traceability, release speed and audit burden, not generic efficiency. A useful pitch shows how the buyer can reduce inspection anxiety, protect margin and avoid supply interruption without disrupting validated processes.
How this list is built
Data sources
This list is built from UK Companies House filings, XBRL accounts data, and semantic analysis of each company's public website. Revenue and headcount figures come from the most recent filed accounts; where the company has not filed, values are estimated using a model trained on filed history and peer benchmarks and are labelled as estimates.
Classification
Rather than relying solely on SIC codes, Firmbase classifies each company semantically: the company's website is crawled, an AI model reads what the company actually sells, and the company is placed into the relevant industry and subsectors. SIC codes are used as one signal but not the only one. This means a company that registered under a generic SIC code but pivoted into (for example) fintech is correctly identified as fintech, not as its original SIC category.
Freshness
The underlying company data is refreshed from Companies House continuously; filings appear in the list within days of submission. The curated list ordering is regenerated when the underlying data moves meaningfully (company count changes by more than 5%, a new company enters the top-ranked segment, or the filed-revenue numbers for the top firms change). You can see the last-updated timestamp near the top of the page.
Also in Leeds
Related directories
Frequently asked questions
How many pharmaceutical companies are there in the Leeds?↓
What counts as a pharmaceutical company in this list?↓
Which are the largest pharmaceutical companies in the Leeds?↓
What do pharmaceutical companies in the Leeds actually do?↓
How does Leeds pharmaceutical compare internationally?↓
How is this list built and how fresh is the data?↓
How big are the typical pharmaceutical companies in the Leeds?↓
Are these mostly new or established pharmaceutical companies?↓
What SIC codes does this use?↓
What buying signals should I look for?↓
Push these 269 companies into your pipeline.
Find the right decision-makers, see verified company data, and export your list in seconds.